Finance entity
All 2 tracked stories fall under one category: earnings. Of the tracked stories, 2 of 2 also mention Datadog, the most common co-covered peer. Across a 164-day span, the pace is roughly 0.1 stories per week. Each story carries 2.5 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: 2d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: earnings. Of the tracked stories, 2 of 2 also mention Datadog, the most common co-covered peer. Across a 164-day span, the pace is roughly 0.1 stories per week. Each story carries 2.5 original sources on average, compared with 2.8 for the broader beat in this window. The 6 average consequence score is below the beat benchmark of 6.3 in the same window. This profile follows 2 Finance stories mentioning Olivier Pomel across the period from March 4, 2026 to August 14, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 3309 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Olivier Pomel. Shared-story counts are live from our verified record — not editorial picks.
MP Materials and Maravai Q2 2026 transcripts released
Call transcripts were published for the rare-earth and life-science companies.
Acacia Research Q2 2026 Earnings Call
Record $114.6M revenue from IP licensing settlement; Life Sciences write-down disclosed.
Q2 2026 earnings show Acacia Research's record $114.6M IP-settlement revenue countered by a Life Sciences write-down, while Dutch Bros grew 32.5%. Datadog, MP Materials, and Maravai add cloud, rare-earth, and biotech signals for investors.
Source: Yahoo! News · Fool
Datadog and agilon health shares experienced significant rallies on March 4, 2026, signaling a robust appetite for high-growth cloud infrastructure and value-based healthcare models. The moves highlight a broader market shift toward companies demonstrating both scale and operational leverage in complex regulatory and technological environments.
Olivier Pomel is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
